Bioworld Financial Watch articles from January 2002

Bioworld Financial Watch archives from January 2002

Investors Turn More Cautious, Sober Up After Financing 'Party'.
January 7, 2002... SAN FRANCISCO -- Talk about a hard act to follow. After 2000's boom, which brought about a nearly hysterical financial ride for the Industry, almost anything would have looked worse. Investors sniffing big profits down the road had jumped...

10 Biggest U.S. Gainers For The Week.
January 7, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Matrix 61.88 Tripos 5.57 MediChem 54.17 Biorcliance 2.34 Demegen 40.00 LION bioscience 2.25...

10 Biggest U.S. Losers For The Week.
January 7, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Percent) ImClone Sys -21.29 ImClone Sys -11.76 Argonaut -20.43 IDEC Pharma -7.46 Visible Genetics -18.03 InterMune -7.25...

Public Financing of Biotechnology: December 2001.
January 7, 2002... Public Financing of Biotechnology: December 2001 I. COMMENCED TRADING IN DECEMBER Company Date Date Shares/ Price Shares (Symbol) (#) Filed Comm. Units (M) Out (M) INITIAL...

Filed And Pending.
January 7, 2002... II. FILED AND PENDING Company Date Shares/ Price Shares (Symbol/ Filed Units Range Out (M) Proposed (M) Symbol) (#) (*) ...

Withdrawn And Postponed.
January 7, 2002... III. WITHDRAWN AND POSTPONED Company Date Shares/ Price Shares (Symbol/ Filed/ Units Range Out (M) Proposed Date (M) Symbol)" Pulled INITIAL OFFERINGS Xcyte...

Other Financings Of Public Biotechnology Companies: December 2001.
January 7, 2002... Other Financings Of Public Biotechnology Companies: December 2001 Total: $1,405.57M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture Capital And Corporate Investments In Biotechnology Companies: December 2001.
January 7, 2002... Venture Capital And Corporate Investments In Biotechnology Companies: December 2001 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $412.12M Company Location Date Amt. (M) Agilix Corp. New Haven,...

Money Raised By Biotech in 2001: January-December.
January 7, 2002... Money Raised By Biotech in 2001: January-December Type of 1($M) F($M) M($M) A($M) M($M) J($M) J($M) financing Public offerings 114.7 724.2 352.4 4.1 50.8 741.2 74.7 Private biotechs 318.7...

BioWorld Stock Report For Public Biotechnology Companies.
January 7, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 12/28 1/4 WK YTD 3D Pharma DDDP 8.45 8.76 ...

London Stock Exchange.
January 7, 2002... LONDON STOCK EXCHANGE Company Symbol 12/28 1/4 %WK %YTD Volume Antisoma ASM 37.5 40.5 8.00 14.08 1049 British Biotech BBG 17.5 18.25 4.29 10.61 4208 Cambridge Ab CAT...

Toronto Stock Exchange.
January 7, 2002... TORONTO STOCK EXCHANGE Company Symbol 12/28 1/4 %WK %YTD Volume Angiotech Pharma ANP 89.2 86.25 -3.31 -3.09 115 Anormed AOM 3.61 3.6 -0.28 4.35 222 AltaRex ...

Analysts offer top stock picks, mull weight of 'Macro' issues.
January 14, 2002... SAN FRANCISCO -- The annual JPMorgan H&Q Healthcare Conference, drawing a record 5,000-plus attendees, closed last week with Its traditional analyst wrap-up, where members of the firm sought to offer a "big picture" outlook on the coming year...

Money raised by biotech in 2002 Vs. 2001.
January 14, 2002... Money Raised By Biotech In 2002 Vs. 2001 Public/ Private Public Other (*) Biotechs Offerings Jan. 1 - Jan. 10, 2002: $100.525M 30 61 9...

10 Biggest U.S. Gainers and Losers for the week.
January 14, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Oxis Int'l 37.50 Gilcad Sciences 7.72 Martek Bio 33.18 Martek Bio 7.00 DOR BioPharma 30.84 Tripos 4.79...

Clinical trial update: December 2001.
January 14, 2002... Clinical Trial Update: December 2001 CANCER Company(*) Product Description (Symbol) Abgenix Inc. ABX-EGF A human monoclonal (ABGX) antibody that...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: December 2001.
January 14, 2002... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: December 2001 CANCER Company Product Description (Symbol) Atrix Laboratories Leuprogel Leuprolide acetate Inc....

FDA submissions, approvals and other actions: December 2001.
January 14, 2002... FDA Submissions, Approvals And Other Actions: December 2001 CANCER Company Product Description (Symbol) GPC Biotech Bryostatin-1 Linked to the AG (Germany: modulation FSE:GPC) ...

Bioworld stock report for public biotechnology companies.
January 14, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 1/4 1/11 WK YTD 3D Pharma DDDP 8.76 8.19 ...

London Stock Exchange.
January 14, 2002... LONDON STOCK EXCHANGE Company Symbol 1/4 1/11 %WK %YTD Volume Antisoma ASM 40.5 33.5 -17.28 -5.63 543 British Biotech BBG 18.25 17.65 -3.29 6.97 2083 Cambridge Ab...

Toronto Stock Exchange.
January 14, 2002... TORONTO STOCK EXCHANGE Company Symbol 1/4 1/11 %WK %YTD Volume Angiotech Pharma ANP 86.25 86.75 0.58 -2.53 147 Anormed AOM 3.6 3.5 -2.78 1.45 333 AltaRex ...

'Grassroots' war over GMOs taking place in United States.
January 21, 2002... One tomato, two tomato, three tomato... hey, where'd they all go? In the case of Calgene, Inc., which introduced its FlavSavr tomato In 1994. they're off the market, having succumbed to sentiment against genetically modified organisms and...

10 biggest U.S. gainers for the week.
January 21, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) LifeCell 27.45 Oxis Int'l 27.27 Hycor Bio 23.24 Flamel Tech 22.55 Questeor Pharma 13.48 Pharsight 13.41 OraPharma 11.11...

10 biggest U.S. losers for the week.
January 21, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Minivant -79.90 Inspire Pharma 75.42 Gliatech 52.94 Cubist Pharma -46.88 ImClone Sys 35.52 Demegen -29.63 Aradigm ...

Grants and awards to biotech companies: Jan. 1 - Dec. 31, 2001.
January 21, 2002... Grants And Awards To Biotech Companies: Jan. 1 - Dec. 31, 2001 Company (*) Funding (Symbol) (**) Institution 3-Dimensional National Institutes Pharmaceuticals Inc. ...

BioWorld stock report for public biotechnology companies.
January 21, 2002... BioWorld stock report for public biotechnology companies Company Symbol Close Close %Change Vol 1/11 1/18 WK YTD (000) 3D Pharma DDDP 8.19 ...

London stock exchange.
January 21, 2002... London stock exchange Company Symbol 1/11 1/18 %WK %YTD Volume Antisoma ASM 33.5 32.5 -2.99 -8.45 2345 British Biotech BBG 17.65 17.5 -0.85 6.06 7572 Cambridge Ab ...

Toronto stock exchange.
January 21, 2002... Toronto stock exchange Company Symbol 1/11 1/18 %WK %YTD Volume Angiotech Pharma ANP 86.75 85.85 -1.04 -3.54 479 Anormed AOM 3.5 3.49 -0.29 1.16 211 AllaRax ...

Money raised by Biotech in 2002 vs. 2001.
January 21, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 Jan. 17, 2002: Jan. 1 Jan. 18, 2001: $268.443M $520.87M Public/Other (*) 116 142 Private Biotechs...

Could ImClone's Erbitux troubles be 'No Big Deal'?
January 28, 2002... As accusations -- many of them contained in lawsuit papers filed by shareholders -- fly right and left in the ImClone Systems Inc. imbroglio related to Erbitux (cetuximab), bystanders are trying to sort out what happened. The bare facts of...

10 Biggest U.S. Gainers & Losers for the Week.
January 28, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Gliatech 42.50 DOR BioPharma 36.15 GalaGen 35.71 V.I. Technal 20.34 Genetronics 18.06 Cytogen 16.25 Carrington 12.78...

U.S. Public Offering Performance By Underwriter: Jan. 1 - Dec. 31, 2001.
January 28, 2002... U.S. Public Offering Performance by Underwriter: Jan. 1 - Dec. 31, 2001 (*) Underwriter Biotechnology Date Company priced ABN Amro ...

Bioworld Stock Report for Public Biotechnology Companies.
January 28, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 1/18 1/25 WK YTD 3D Pharma DDDP 7.74 7.28 ...